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Recurrent aphthoid stomatitis is characteristically observed 
in children and adolescents in the form of painful relapsing 
ulcers in the oral mucosa unaccompanied by evidences 
of systemic disease. The ulcers appear every one or two 
weeks for at least one entire year. Some patients suspected 
for recurrent aphthoid stomatitis develop lesions in atypical 
sites - mainly in the larynx - concurrently to the ones found 
in the oral mucosa. Aim: this study aims to describe a 
series of recurrent aphthoid stomatitis patients with atypical 
laryngeal injuries. Study design: this is a case series study. 
Materials and method: patients diagnosed with recurrent 
aphthoid stomatitis with oral mucosa ulcers and laryngeal 
symptoms without altered lab test results and no evidence of 
systemic disease underwent fibroscopic examination, oral and 
laryngeal biopsies, followed by specimen evaluation by direct 
immunofluorescence. Results: all six patients in this series 
had acute and chronic inflammatory processes according to 
pathology studies and negative direct immunofluorescence 
test results. Conclusion: laryngeal involvement in recurrent 
aphthoid stomatitis is rare. Therefore, during diagnostic 
examination thorough clinical history and meticulous physical 
examination accompanied by fibroscopic examination are 
necessary. When atypical lesions are found, biopsies for 
histological evaluation and direct immunofluorescence tests 
are required.
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microscopy.
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INTRODUCTION
Recurrent aphthous stomatitis (RAS) is characteristi-
cally observed in children and adolescents in the form of 
painful relapsing ulcers in the oral mucosa unaccompanied 
by evidences of systemic disease. The ulcers appear every 
one or two weeks for at least one entire year1. Aphthous 
injuries apparently disconnected from underlying diseases 
or syndromes are somewhat frequently seen in our daily 
practice.
Oral injuries may mimic other conditions or be part 
of the clinical manifestations seen in various diseases, as is 
the case of autoimmune vesicular-bullous diseases. Fully 
evolved sores may look like pemphigus vulgaris (PV) or 
benign mucous membrane pemphigoid (BMMP), two 
conditions that frequently involve the laryngeal mucosa2,3.
Cases suggestive of RAS with concurrent non-
specific laryngeal lesions ask not only for careful analysis 
of clinical history, physical examination, and lab workup, 
but may also require biopsy followed by pathology tests 
and immunofluorescence labeling so a proper diagnosis 
is established.
Direct immunofluorescence (DIF) on RAS, as des-
cribed by Ship4, is utterly important in the establishment 
of a differential diagnosis from the atypical forms of RAS 
(in which test results are negative) and vesicular-bullous 
diseases (in which fluorescence is positive for oral and/
or laryngeal epithelium)4.
OBJECTIVE
This study aims to describe a series of six patients 
with oral ulcers and clinical history compatible with RAS, 
added by atypical laryngeal signs not compatible with any 
previously described manifestation of recurrent aphthous 
stomatitis.
MATERIALS AND METHOD
This is a retrospective study featuring six consecu-
tive patients seen from 2002 to 2004 by the stomatology 
group of a university hospital’s ENT Clinic; all patients had 
aphthous injuries that appeared and evolved atypically.
Enrolled patients signed a free informed consent 
term. This study was approved by our institution’s ethics 
committee under permit 876/04, as part of a Project inves-
tigating the clinical, pathological and genetic characteristics 
of RAS patients.
All enrolled patients were submitted to a protocol 
that consisted of general and clinical interviews, physical 
examination - mainly of the oral cavity, nasal fibroscopic 
examination using a flexible Olympus 3.4mm ENF Type 
P4 scope and a rigid 70-degree Storz (Hopkins) laryngeal 
scope connected to a 250-Watt halogen light source.
Lab workup included the following: complete blood 
count, coagulation profile, serum ferritin, G6PD dosage 
(glucose-6-phosphate dehydrogenase), antinuclear factor 
(ANF), rheumatoid factor (RF), serology for lues (RSS and 
FTA-ABS), anti-HIV 1 and 2, serum immunoglobulin (Ig) 
A, G and M, C-reactive protein.
Oral and laryngeal biopsies were performed to rule 
out other diseases affecting the oral cavity and to produce a 
differential diagnosis for RAS (Behçet disease, pemphigus, 
pemphigoid, erythema multiforme and others).
Oral biopsy procedure: patients were administered 
an injection of 2% xylocaine without vasoconstrictor; oral 
biopsy was performed using a 4-mm punch; specimens 
were obtained from the mucosa adjacent to the sore for 
direct immunofluorescence and from the transition zone 
between the injured and healthy portions of the mucosa 
for pathology workup.
Laryngeal mucosa biopsy was performed under 
general anesthesia. Patients underwent laryngeal micro 
surgery and had two specimens removed for pathology 
workup and DIF.
Enrollment criteria:
• clinical history compatible with RAS, i.e., episodes 
of aphthous sores in the oral cavity occurring in monthly 
or shorter intervals for at least one year;
• presence of aphthous injury in the oral mucosa;
• absence of altered results in the tests order as 
part of the protocol;
• absence of clinical signs and/or test results com-
patible with systemic disease characterized by oral lesions.
• no use of topical corticosteroids on the sores at 
least two weeks prior to biopsy.
Exclusion criteria:
• clinical history not compatible with RAS;
• presence of altered results in the tests order as 
part of the protocol;
• presence of clinical signs and/or test results com-
patible with systemic disease characterized by oral lesions.
• use of topical corticosteroids on the sores within 
two weeks prior to biopsy.
RESULTS
All patients enrolled in our study had ’atypical 
aphthous injuries.’ Three were males and three were fe-
males, with ages ranging between 22 and 64 years - mean 
age of 38.8 years (Table 1).
Lab workup indicated the presence of oral and 
laryngeal mucosa ulcers and acute/chronic submucosal 
inflammation in all patients. Stains for fungi/granulomatosis 
were negative, as well as DIF (Fig. 1).
Physical examination revealed four patients had 
oral lesions (Fig. 2), some active and some healing. Nasal 
fibroscopy showed additionally that all six patients had 
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laryngeal injuries in various locations: epiglottis, arytenoi-
ds, and ventricular bands (Table 1).
The most frequently reported symptoms were pain, 
odynophagia, and dysphagia, all compatible with RAS. 
Hoarseness was also mentioned by 66.6% of the patients 
- all of whom found to have laryngeal injuries.
Most lesions were major, with sizes ranging between 
1.0 cm (smallest) and 4.0 cm (largest).
Patients were treated with dapsone 100 mg/day 
initially combined with oral steroids - prednisone (30 mg/
day); the latter was gradually removed after one month 
of treatment.
Patients evolved to full laryngeal injury remission 
and partial oral injury remission. They are currently being 
followed up on a monthly basis, and no adverse develo-
pments have been reported to date.
DISCUSSION
Laryngeal injuries are not commonly seen in con-
junction with RAS. We are not aware of any other study 
in which laryngeal involvement has been reported in ca-
ses of RAS. On the other hand, laryngeal involvement in 
cases of pemphigus vulgaris and other vesicular-bullous 
diseases is frequent3.
Our study detected aphthous injuries concurrently 
to oral injuries in various sites in the larynx such as the 
epiglottis, aryepiglottic folds, ventricular bands, and aryte-
noids (Figs. 3 and 4). Given such atypical manifestation, 
direct immunofluorescence was required to produce a 
differential diagnosis4. Direct immunofluorescence perfor-
med upon oral and laryngeal mucosa specimens yielded 
negative results.
Some authors have coined the term ’complex 
aphthosis’ to characterize the constant presence of oral 
lesions or concurrent oral and genital lesions after ruling 
out Behçet disease (BD)5-7. In other words, complex 
Table 1. Characteristics of patients with atypical RAS
Patient Age Gender Complaints Involved site Lesion recurrence
Lesion size 
(diameter)
1 22 Female Odynophagia + cough
Tongue
Larynx (epiglottis)
Twice a month for 
5 years
1,5 a 2,5 cm
2 26 Male
Odynophagia + Dyspha-
gia + Hoarseness
Larynx (ventricular band)
Healing tongue
Twice a month for 
2 years
1,5 a 3,0 cm
3 29 Male
Odynophagia + Dys-
phagia + Hoarseness + 
Dyspnea
Larynx (epiglottis)
Lips and tongue healing
Monthly for 18 
months
1,5 a 3,0 cm
4 44 Female Dysphagia + Dyspnea
Larynx (aryepiglottic fold)
Lip
Every 20 days for 
18 months
1,5 a 3,5 cm
5 48 Male
Dysphagia + Hoarse-
ness
Larynx (ventricular band, arytenoids 
and epiglottis)
Monthly for 8 
years
1,0 a 4,0 cm
6 64 Female
Odynophagia + Hoar-
seness
Larynx (arytenoids)
Palate, tongue and lips healing
Monthly for 18 
months
1,5 a 3,0 cm
Figure 1. Direct immunofluorescence of oral mucosa: patients with 
atypical RAS - absent fluorescence.
Figure 2. Aphthous lesion in oral mucosa of RAS patient.
663
Brazilian Journal of otorhinolaryngology 75 (5) SeptemBer/octoBer 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
aphthosis could also be an atypical manifestation of RAS. 
However, forty-two complex aphthosis patients studied 
by these authors failed to show laryngeal involvement7. 
And none of our patients had genital lesions and/or other 
signs and symptoms of BD.
The diagnosis of BD is eminently clinical, and 
requires the satisfaction of a number of conditions for 
confirmation: recurring oral aphthae, genital ulcers and/
or uveitis and/or skin lesions8. Histological examination of 
the injuries produced by this disease shows vasculitis with 
perivascular leukocytic infiltration9. Once again, few are the 
cases of laryngeal involvement in BD patients. Such cases 
are usually reported when patients have advanced disease 
and complications such as pharyngolaryngeal stenosis9-11.
Although rare, laryngeal lesions occurring concur-
rently with oral lesions are observed in severe cases of 
erythema multiforme12. However, these ulcers are of acu-
te origin and differ clinically from those of our patients, 
whose oral lesions are recurrent.
Laryngeal manifestations are also reported in the 
literature for Crohn’s disease (CD)13-15. CD is a granuloma-
tous inflammatory disease that may involve any portion of 
the gastrointestinal tract, including the oral cavity.
Most common symptoms are abdominal pain and 
diarrhea alternating to intestinal obstruction16. Skin, joints, 
and respiratory mucosa (nasal fossa, hypopharynx, and 
larynx) are cited as other possible areas of manifestation17.
The diagnosis for CD is produced from clinical and 
colonoscopy/biopsy findings positive for inflammatory 
granuloma. The most common finding in the CD involved 
larynx is edema, followed by ulcers and granulomatous 
processes13.
None of our patients had symptoms indicative of 
Crohn’s or any other inflammatory intestinal disease throu-
ghout the follow-up period. Similarly, histology findings 
were never suggestive of Crohn’s disease.
CONCLUSION
Thorough clinical and physical examination, nasal 
fibroscopy included, are required during diagnosis, as 
laryngeal involvement is rare in recurrent aphthous stoma-
titis. When facing atypical lesions, biopsies are necessary 
for histology examination and direct immunofluorescence 
tests.
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